Aptamers and in-beam PET for advanced diagnosis and therapy optimisation

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 33, Issue 9, 2006, Pages 1095-1097

  Lucignani, Giovanni ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; ANTINEOPLASTIC AGENT; APTAMER; CANCER VACCINE; NANOPARTICLE; NANOPARTICLE APTAMER; NUCLEIC ACID; NUCLEIC ACID APTAMER; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; RNA; RNA APTAMER; TECHNETIUM 99M; TENASCIN; UNCLASSIFIED DRUG;

BREAST CANCER; BREMS RADIATION; DRUG CONJUGATION; GLIOBLASTOMA; HUMAN; IN BEAM POSITRON EMISSION TOMOGRAPHY; ISOTOPE LABELING; MOLECULAR IMAGING; NUCLEAR MEDICINE; PHOTON THERAPY; POSITRON EMISSION TOMOGRAPHY; RADIOACTIVITY; RADIODIAGNOSIS; SHORT SURVEY; SIGNAL NOISE RATIO; TUMOR LOCALIZATION;

APTAMERS, NUCLEOTIDE; APTAMERS, PEPTIDE; HUMANS; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; SELEX APTAMER TECHNIQUE;

EID: 33747042502     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0210-7     Document Type: Short Survey

References (13)

1. Pestourie C, Tavitian B, Duconge F. Aptamers against extracellular targets for in vivo applications. Biochimie 2005;87:921-930
2. Proske D, Blank M, Buhmann R, Resch A. Aptamers - basic research, drug development, and clinical applications. Appl Microbiol Biotechnol 2005;69:367-374
3. Hicke BJ, Stephens AW, Gould T, Chang YF, Lynott CK, Heil J, et al. Tumour targeting by an aptamer. J Nucl Med 2006;47:668-678
4. Gambhir SS. Using radiolabeled DNA as an imaging agent to recognize protein targets. J Nucl Med 2006;47:557-558
5. Becker KC, Becker RC. Nucleic acid aptamers as adjuncts to vaccine development. Curr Opin Mol Ther 2006;8:122-129
6. Farokhzad OC, Karp JM, Langer R. Nanoparticle-aptamer bioconjugates for cancer targeting. Expert Opin Drug Deliv 2006;3:311-324
7. Bennett GW, Archambeau JO, Archambeau BE, Metzer JI, Wingate CL. Visualization and transport of positron emission from proton activation in vivo. Science 1978;200:1151-1153
8. Enghardt W, Fromm WD, Geissel H, Heller H, Kraft G, Magel A, et al. The spatial distribution of positron-emitting nuclei generated by relativistic light ion beams in organic matter. Phys Med Biol 1992;37:2127
9. Paans AMJ, Schippers JM. Proton therapy in combination with PET as monitor: a feasibility study. IEEE Trans Nucl Sci 1993;40:1041-1043
10. Vynckier S, Derreumaux S, Richard F, Bol A, Michel C, Wambersie A. Is it possible to verify directly a proton-treatment plan using positron emission tomography? Radiother Oncol 1993;26:275-277
11. Pawelke J, Byars L, Enghardt W, Fromm WD, Geissel H, Hasch BG, et al. The investigation of different cameras for in-beam PET imaging. Phys Med Biol 1996;41:279-296
12. Crespo P, Shakirin G, Enghardt W. On the detector arrangement for in-beam PET for hadron therapy monitoring. Phys Med Biol 2006;51:2143-2163
13. Muller H, Enghardt W. In-beam PET at high-energy photon beams: a feasibility study. Phys Med Biol 2006;51:1779-1789